"Wearable intelligence for better health outcomes"
US-based developer of wearable sensors and digital health platforms for clinical trials and patient monitoring.
BioSensics, founded in 2007 by scientists from Harvard University and headquartered in Newton, Massachusetts, USA, develops clinically validated wearable sensor systems and digital health platforms for healthcare applications. The company's sensor technologies measure movement-based biomarkers including gait, balance, physical activity, frailty, fall risk, tremor, and motor function. Its Sensor-Integrated Digital Platform supports remote patient monitoring and clinical trial data collection across therapeutic areas including stroke, neurology, oncology, and musculoskeletal disorders.
BioSensics products have been used in more than 50 clinical studies and referenced in over 200 scientific publications. The company has received NIH funding including a $3 million award to develop the PAMSys Voice wearable sensor for speech biomarker tracking.
Primary type & automation activities this supplier delivers:
Clinically validated wearable sensor system for continuous monitoring of movement biomarkers in clinical trials and patient care.
Contact BioSensics
WEBSITE
https://www.biosensics.comPHONE
+1 (888) 589.6213HEADQUARTERS
United States
Company Facts
Founded
2007
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-
